A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus

[21] Tanaka T(1992)A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1618-1624

[22] Matono S(1986)Small cell carcinoma of the lung to operate or not? Surgical experience and results Thorac Cardiovasc Surg 34 71-76

[23] Nagano T(1996)Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine J Clin Oncol 14 806-813

[24] Huncharek M(1999)Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 265-271

[25] Muscat J(2005)Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903 Clin Cancer Res 11 5534-5538

[26] Medgyesy CD(2006)Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902 J Clin Oncol 24 5247-5252

[27] Wolff RA(2019)Small cell carcinoma of the esophagus: a nationwide analysis of treatment and outcome at patient level in locoregional disease Am J Clin Oncol 42 534-538

[28] Putnam JB(2012)Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC? Int J Clin Oncol 17 610-615

[29] Pantvaidya GH(2017)Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base Dis Esophagus 30 1-5

[30] Pramesh CS(2013)Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma Radiother Oncol 106 317-322

[21] Tanaka T(1992)A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1618-1624

[22] Matono S(1986)Small cell carcinoma of the lung to operate or not? Surgical experience and results Thorac Cardiovasc Surg 34 71-76

[23] Nagano T(1996)Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine J Clin Oncol 14 806-813

[24] Huncharek M(1999)Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 265-271

[25] Muscat J(2005)Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903 Clin Cancer Res 11 5534-5538

[26] Medgyesy CD(2006)Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902 J Clin Oncol 24 5247-5252

[27] Wolff RA(2019)Small cell carcinoma of the esophagus: a nationwide analysis of treatment and outcome at patient level in locoregional disease Am J Clin Oncol 42 534-538

[28] Putnam JB(2012)Non-surgical approach to small cell carcinoma of the esophagus: does this rare disease have the same tumor behavior as SCLC? Int J Clin Oncol 17 610-615

[29] Pantvaidya GH(2017)Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base Dis Esophagus 30 1-5

[30] Pramesh CS(2013)Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma Radiother Oncol 106 317-322